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Summary
The predominant morphotype of mycobacteriophage
virions has a DNA-containing capsid attached to a
long ﬂexible non-contractile tail, features characteris-
tic of the Siphoviridae. Within these phage genomes
the tape measure protein (tmp) gene can be readily
identiﬁed due to the well-established relationship
between the length of the gene and the length of the
phage tail – because these phages typically have long
tails, the tmp gene is usually the largest gene in the
genome. Many of these mycobacteriophage Tmp’s
contain small motifs with sequence similarity to host
proteins. One of these motifs (motif 1) corresponds to
the Rpf proteins that have lysozyme activity and func-
tion to stimulate growth of dormant bacteria, while the
others (motifs 2 and 3) are related to proteins of
unknown function, although some of the related pro-
teins of the host are predicted to be involved in cell
wall catabolism. We show here that motif 3-containing
proteins have peptidoglycan-hydrolysing activity and
that while this activity is not required for phage viabil-
ity, it facilitates efficient infection and DNA injection
into stationary phase cells. Tmp’s of mycobacterioph-
ages may thus have acquired these motifs in order to
avoid a selective disadvantage that results from
changes in peptidoglycan in non-growing cells.
Introduction
All bacteriophages are posed with the common problem
of how to accomplish injection of their genomes across
the walls and membranes of their host bacterial cells
(Molineux, 2001; 2006). Phages that infect Gram-
negative bacteria are faced with two membrane layers,
but with only a relatively thin peptidoglycan layer within
the periplasmic space (Vollmer and Holtje, 2001). Never-
theless, the virion particles of several phages of Gram-
negative hosts have been shown to contain hydrolytic
activities targeted against peptidoglycan; for example,
virions of T4, T7, f6 and PRD1 contain either lysozyme,
transglycosylase or endopeptidase activities (Nakagawa
et al., 1985; Caldentey and Bamford, 1992; Moak and
Molineux, 2000; Rydman and Bamford, 2000; Kanamaru
et al., 2002). The location of these functions within the
virions is varied. For example, in phage T4 the lysozyme
(gp5) is a component of the baseplate’s central hub
(Mosig et al., 1989), whereas the transglycosylase of T7
(gp16) is one of three proteins present within the capsid
(Struthers-Schlinke et al., 2000). In f6 the endopeptidase
(P5) is located between the nucleocapsid surface and the
viral membrane (Caldentey and Bamford, 1992), and in
PRD1 both a transglycosylase (P7) and a 1,4 beta-N-
acetylmuramidase activities (P15) are located within the
viral membrane (Rydman and Bamford, 2002). While the
speciﬁc roles of these peptidoglycan-degrading activities
may differ somewhat, it is likely that they share a common
function in facilitating efficient infection of host cells, either
by enabling access to the cytoplasmic membrane or
mediating transfer of virion DNA from the capsid to the
cellular cytoplasm.
Phages that infect Gram-positive hosts have only a
single cytoplasmic membrane to contend with, but the
peptidoglycan layer is usually much thicker than in Gram-
negative bacteria. Not surprisingly, the presence of mura-
lytic activities in the virions of such phages (including
those that infect Lactococcus lactis, Staphylococcus
aureus and Bacillus subtilis) is not uncommon (Moak and
Molineux, 2004), and in the L. lactis phage Tuc2009 there
is a tail-associated lysin involved in localized cell wall
degradation (Kenny et al., 2004). Phages that infect
mycobacterial hosts must not only overcome the mem-
brane and peptidoglycan barriers but must also contend
with thick complex cell walls that contain long carbon
chain mycolic acids (Brennan, 2003). However, virion-
associated enzymatic activities that degrade peptidogly-
can, mycolic acids or other cell wall components have yet
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gies of many mycobacteriophages have been examined,
all contain either a contractile tail (Myoviridae) or a long
ﬂexible non-contractile tail (Siphoviridae), and to our
knowledge no short-tailed phages (e.g. Podoviridae) have
been isolated. As short-tailed phages are prevalent
among phages that infect a variety of other bacterial
hosts, the question arises as to whether longer phage tails
are needed to traverse complex mycobacterial cell walls.
A comparative genomic analysis of 14 mycobacterioph-
ages reveals that several contain unusual sequence
motifs embedded within their tape measure proteins
(Tmp’s) (Pedulla et al., 2003). Three motifs were identiﬁed
(motifs 1, 2 and 3) all of which have sequence similarity to
previously identiﬁed host proteins that are not associated
with phage or prophage genomes. Motif 1 (present in
mycobacteriophage Barnyard) is related to a family of
proteins typiﬁed by the Resuscitation Promoting Factor
(Rpf) of Micrococcus luteus but found in many other bac-
teria (Mukamolova et al., 2002), motif 2 (present in myco-
bacteriophages Che9c, Cjw1, Barnyard and Rosebush) is
related to a small Mycobacterium tuberculosis protein of
unknown function (Rv1115), and motif 3 (mt3, present in
TM4, Che8 and Omega) is related to two small
M. tuberculosis proteins Rv0320 and Rv1728c (Pedulla
et al., 2003). The role of these motifs has remained
unclear, although their presence within the Tmp’s of these
phages is somewhat surprising because these proteins
have been previously shown to play an important role in
phage tail assembly, such that there is a direct correlation
between the length of the tmp gene and the length of the
phage tail (Katsura and Hendrix, 1984). Indeed, small
deletions and duplications within the lambda tmp gene (H)
yields phage particles with correspondingly shorter or
longer tails (Katsura and Hendrix, 1984; Katsura, 1987); a
similar mutational analysis has been performed with lac-
tococcus phage TP901-1 with similar conclusions (Peder-
sen et al., 2000). The presence of the small sequence
motifs suggests that Tmp’s may play important roles other
than in tail assembly.
Recently, it has been demonstrated that the Rpf-related
proteins have structural similarity to lysozymes and
soluble transglycosylases, and can hydrolyse peptidogly-
can in vitro (Cohen-Gonsaud et al., 2005; Keep et al.,
2006; Telkov et al., 2006). However, they were initially
identiﬁed through the ability of the Rpf protein to resusci-
tate the growth of dormant Micrococcus luteus cells
(Mukamolova et al., 1998). The peptidoglycan-degrading
activity appears to be required for resuscitation (Muka-
molova et al., 2006) suggesting that this either leads to
activation of a cell cycle step, or possibly releases other
growth promoting signals from lysed cells (Keep et al.,
2006). While the role of motif 1 in Barnyard remains
unclear, these observations raise the question as to
whether motifs 2 and 3 are also involved in the degrada-
tion of peptidoglycan or other cell wall components.
In this paper we explore the activity of mt3 present
within the tape measure protein of mycobacteriophage
TM4 and its homologous proteins encoded by the Myco-
bacterium smegmatis host. We show that the host pro-
teins MSMEG0642, MSMEG3721 and TM4 Tmp mt3
contain peptidoglycan-degrading activity. Removal of mt3
from the TM4 Tmp generates virions with predictably
shortened tails but which are still viable. While the paren-
tal phage has a similar efficiency of plating on stationary
phase cells relative to exponentially growing cells, the
efficiency of plating of the mt3 deletion mutant on station-
ary phase cells is reduced approximately 50% relative to
exponentially growing cells; mutant phage with a single
amino acid substitution of a well-conserved tryptophan
residue in the motif has a similar phenotype. This reduc-
tion in plating efficiency is not due to a change in adsorp-
tion but as a result of a defect in DNA injection as
indicated by the behaviour of luciferase reporter phage
derivatives. We conclude that Tmp mt3 confers the ability
of TM4 to efficiently infect stationary phase cells that
probably have thicker or more highly cross-linked
peptidoglycan in their cell walls, and confers a selective
advantage over those phages that do not possess this
capability.
Results
Relationship of TM4 Tmp mt3 to a family of host
proteins
We showed previously that the conserved sequence mt3
present in the tape measure proteins of mycobacterioph-
ages TM4, Omega, and Che8 is related to M. tuberculosis
Rv1728c and Rv0320, two putative M. tuberculosis hypo-
thetical conserved proteins of unknown function, as well
as to a putative peptidase of Rhodococcus equi (Pedulla
et al., 2003). Rv1728c and Rv0320 are highly conserved
among sequenced mycobacterial genomes including
M. tuberculosis CDC 1551, Mycobacterium bovis
AF2122/97, Mycobacterium avium ssp. paratuberculosis
str K10 and M. smegmatis mc2155; the M. smegmatis
homologues, MSMEG3721 and MSMEG0642, share
70% and 58% amino acid sequence identity with
M. tuberculosis Rv1728c and Rv0320 respectively
(Fig. 1). The conserved motif is located at positions
87–194 and 106–208 in MSMEG3721 and MSMEG0642
respectively (Fig. 1).
A protein domain search using ProDom (Servant et al.,
2002; Bru et al., 2005) revealed that TM4 Tmp mt3 is
present as a domain within at least two dozen bacterial
proteins (Fig. 1). The functions of these have not been
experimentally demonstrated, although several have
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lism or functioning as metalloendopeptidases, mainly
because of the presence of other sequence motifs (e.g.
LysM, VanY, Transglycosylas) found in cell wall enzymes.
Arole for the members of this family in cell wall catabolism
is supported by the bioinformatic prediction that all of the
bacterial proteins including MSMEG3721, MSMEG0642,
Rv1728c and Rv0320 contain putative signal sequences
as well as putative processing sites (at positions 25/66
in MSMEG3721/Rv1728c and 40/38 in MSMEG0642/
Rv0320 respectively). Members of the family also include
zinc metalloendopeptidases, which can act lytically
against bacterial cells (Li et al., 1998; Nilsen et al., 2003).
The output from ProDom includes the Tmp of phage
TM4, as well as a protein (gp95) encoded by mycobacte-
riophage Bxz1 whose virions possess a contractile tail
(Pedulla et al., 2003). However, it does not includes the
Tmp’s of mycobacteriophages Omega and Che8 that
were previously described as including mt3 (Pedulla
et al., 2003), even though these can be readily included in
the alignment using CLUSTALX. A plausible explanation is
that Omega and Che8 Tmp’s do not possess a well-
conserved isoleucine-tryptophan sequence at the centre
of the motif, where the tryptophan is substituted with phe-
nylalanine (Fig. 1).
MSMEG3721 and MSMEG0642 are
peptidoglycan-degrading enzymes
To address whether this family of proteins is active in cell
wall catabolism we have taken three approaches to
characterize the host proteins MSMEG3721 and
MSMEG0642. First, we examined the cellular localization
of MSMEG3721 in M. smegmatis, because cell wall
enzymes are likely to be located on the exterior of the cell.
To monitor the expression and localization of the protein
we overexpressed and puriﬁed it from Escherichia coli
cells and raised polyclonal antibodies. Surprisingly,
although these antibodies are of respectable titer and
readily recognize both puriﬁed protein and MSMEG3721
expressed in E. coli (data not shown), we were unable to
detect expression of the endogenous protein in either
exponentially growing or stationary phase cells of
M. smegmatis (data not shown).
If MSMEG3721 is involved in cell wall catabolism it is
perhaps not surprising that the protein is expressed at
Fig. 1. Amino acid sequence alignment of proteins related to Tmp
mt3. Amino acid sequence alignment of proteins containing the
ProDom domain that corresponds to mt3 using MultAlign. Omega
gp34 and Che8 gp14 were included in the alignment using
CLUSTALX. Red letters, high consensus (90%); blue letters, low
consensus (50%); ! is anyone of IV; # is anyone of NDQE. For
Mycobacterial and Mycobacteriophages proteins the correspondent
gene name is also shown. The conserved W residue is highlighted.
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problem we attempted to elevate the expression by
cloning the gene into extrachromosomal plasmid vectors
containing the strong M. bovis BCG hsp60 promoter
(Stover et al., 1991), and constructed plasmid derivatives
containing the gene both with and without its putative
signal peptide (SP). Interestingly, while the protein lacking
the SP was readily detected and is primarily located within
the cytoplasm, we were not able to detect any protein
expression from the full-length gene (Fig. 2A). Presum-
ably, the protein is either not expressed or is processed
and rapidly degraded; it is unlikely that it is secreted
because we do not detect protein in the culture superna-
tant (Fig. 2A). However, when expression of the protein
was induced from the regulatable acetamidase promoter
(Parish et al., 1997), we could detect small amounts of the
protein expressed with SP (Fig. 2B). Fractionation of the
induced cells shows that the protein is primarily located
within the cell wall fraction (Fig. 2C); we could not detect
any of this protein in spent growth medium (Fig. 2C).
To further elucidate the possible functions of
MSMEG0642 and MSMEG3721 we constructed knockout
mutants for each gene individually and with both together.
None of the three mutants showed any obvious growth
Fig. 2. Localization and biochemical activities
of MSMEG3721/MSMEG0642.
A. Western blot analysis of MSMEG3721 with
or without the putative SP overexpressed in
M. smegmatis using an extrachromosomal
plasmid (pMP2 and pMP1 respectively).
Samples of cell fractions are indicated.
B. MSMEG3721 gene containing the putative
SP was cloned under control of an
acetamidase promoter in an integrative vector
(pMP4). After integration in M. smegmatis,
cells were grown in TH9 containing succinate
with and without the acetamide inducer.
Proteins were extracted from M. smegmatis
cells transformed with pJL37 (empty vector
control; lane 1), pMP2 (control of expression
w/out SP; lane 2), pMP4 (grown in the
absence of acetamide; lane 3), pMP4 (grown
in the presence of acetamide; lane 4).
C. Cell localization of MSMEG3721 w/SP
overexpressed from pMP4 in the presence of
acetamide. In all cases proteins were
detected in the indicated cell fractions using
an a-MSMEG3721 polyclonal antiserum.
D. Partially puriﬁed protein preparations were
separated by SDS-PAGE (right panel) or
separated and analysed in a zymogram (left
panel) for peptidoglycan-hydrolysing activity.
Lanes 1 and 6, MSMEG3721 recombinant
protein (10 mg); 2 and 7 MSMEG0642
recombinant protein (10 mg); lanes 3 and 8,
mock puriﬁcation using E. coli cells
transformed with pET-28a (empty vector);
lanes 4 and 9 lysozyme (5 mg) used as
positive control; lanes 5 and 10, b-casein
(10 mg) used as a negative control.
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Presumably, either they do not provide functions essential
for growth or there is an additional gene that is functionally
redundant to these. We note that in E. coli a mutant
lacking three known endopeptidases (PBPs 4 and 7, and
MepA) is viable, presumably for similar reasons (Young,
2001). However, as MSMEG0642 and MSMEG3721
could also be candidates for peptidoglycan hydrolases,
we decided to test whether the mutants exhibited any
changes to antibiotics that are known to act on peptidogly-
can biosynthesis. Interestingly, we found that all three of
the mutants show a modest but signiﬁcant increase in
resistance to vancomycin (Table 1 and Fig. S1), an
antibiotic that binds to the D-alanyl-D-alanine peptide ter-
minus of the nascent peptidoglycan-lipid carrier, is incor-
porated into nascent peptidoglycan polymer, and prevents
full cross-linking by the transpeptidases. This increase in
resistance suggests that the peptidoglycan is altered in
these mutant strains, consistent with the hypothesis that
MSMEG0642 and MSMEG3721 are involved in pepti-
doglycan synthesis or remodelling. Complementation
studies are consistent with the interpretation that the loss
of MSMEG0642 and/or MSMEG3721 functions contrib-
utes to vancomycin resistance although the data are
complex because a restoration of normal drug sensitivi-
ties is only observed when the complementing gene
is provided on an extrachromosomal plasmid (Table 1),
and not when on an integration-proﬁcient plasmid
(data not shown). Finally, we note that a mutant of
a known M. smegmatis peptidoglycan endopeptidase
(PBP4, MSMEG6076, a putative D-alanyl-D-alanine
carboxypeptidase/D-alanyl-D alanine-endopeptidase) is
also resistant to vancomycin and could thus be function-
ally redundant to MSMEG0642 and MSMEG3721
(Table 1).
To more directly assess the enzymatic activity of
MSMEG0642 and MSMEG3721 we tested their ability to
generate a zone of clearing in a zymogram assay. In this
assay proteins are separated by SDS gel electrophoresis
through a matrix containing peptidoglycan, renatured, and
allowed to degrade the peptidoglycan; the peptidoglycan
is then stained with methylene blue (Moak and Molineux,
2004). Proteins capable of degrading peptidoglycan gen-
erate a white zone of clearing on a dark background. As
shown in Fig. 2D, both MSMEG3721 and MSMEG0642
are positive in this assay. While the speciﬁc activity of
these proteins appears to be lower than that of a
lysozyme control (perhaps four- to ﬁvefold reduced), rela-
tive activities must be interpreted cautiously because
enzyme renaturation efficiencies can be highly variable
(Fig. 2D).
TM4 gp17 mt3 supports peptidoglycan hydrolytic activity
The analysis described above presents a strong case
that MSMEG3721 and MSMEG0642 are involved in cell
wall catabolism. As mycobacteriophage TM4 is clearly
related to these proteins through the presence of mt3 in
the Tmp (Fig. 1), we tested whether TM4 gp17 is active
in a zymogram assay. While we were unable to detect
any activity from whole phage particles (data not shown)
it is plausible that the relatively low abundance and large
size of the protein (1229 amino acids) interferes with
efficient refolding of the protein within the gel. As
attempts to express either the complete TM4 gp17
protein or parts of it in E. coli failed, we constructed a
hybrid protein where the resident motif (107 residues of
the 216 total amino acids) in MSMEG3721 was replaced
by mt3 of TM4 gp17 (114 residues) (Fig. 3A); this hybrid
protein supports peptidoglycan hydrolysis in a zymo-
gram assay (Fig. 3B). As we have not been able to suc-
cessfully overexpress a MSMEG3721 derivative in which
the conserved motif is deleted, we cannot eliminate the
possibility that the peptidoglycan-hydrolysing activity
resides elsewhere in the MSMEG3721-derived portion of
the hybrid protein. However, as the longest segment of
MSMEG3721-derived sequence is only 62 amino acids
(see Experimental procedures), and bioinformatic analy-
sis does not reveal any conserved sequence motifs
other than that described above, we prefer the parsimo-
nious explanation that the TM4 Tmp mt3 provides the
catalytic residues.
Table 1. Minimal inhibitory concentration (MIC) for vancomycin of wt and mutant strains.
Strain Vancomycin MIC (mgm l
-1)  SD R factor*
Wild type 2.43  0.04 1
MSMEG3721::res-hyg-res 5.26  0.20 2.2
MSMEG0642::res-hyg-res 4.83  0.09 2.0
MSMEG0642D/3721::res-hyg-res 4.99  0.18 2.1
MSMEG6076::res-hyg-res 12.41  0.70 5.1
wt (pPG1) 4.64  0.04 1
MSMEG0642D/3721::res-hyg-res (pPG1) 8.75  0.03 1.9
MSMEG0642D/3721::res-hyg-res (pMP8) 4.51  0.09 1
MSMEG0642D/3721::res-hyg-res (pMP9) 4.72  0.16 1
Experiments were done by triplicate and the mean for the MIC and the SD are shown.
*R factor represents the resistance factor of each strain compared with M. smegmatis mc
2155 (wild type).
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mt3’s in their Tmp’s
In order to determine the role of the TM4 Tmp motif in vivo
we constructed TM4 derivatives that either lack the Tmp
motif (Fig. 4) or carry a non-functional one (Fig. 5). To
construct these mutant derivatives of TM4 we adapted the
E. coli recombineering system that utilizes a highly effi-
cient recombination system and short DNA substrates
(Court et al., 2002); as TM4 does not replicate in E. coli
we used a previously constructed shuttle phasmid
phAE87 that replicates as a large cosmid-like plasmid in
E. coli and a phage in M. smegmatis. To construct the mt3
deletion derivative, a 200 bp DNA fragment containing
TM4 Tmp coding sequences lacking mt3 was electropo-
rated into a recombineering strain of E. coli and cells
recovered in the absence of selection (see Experimental
procedures). Phasmids isolated from pools of recovered
cells were screened by PCR for the presence of a 342 bp
deletion and the DNA of one candidate (phAE87D17mt3)
was puriﬁed and conﬁrmed by DNA sequencing. The
restriction digestion patterns of the mutant are identical to
the parent DNA with the exception of the changes
expected from the deletion in gene 17. A similar strategy
(Fig. 5) was used to construct a point mutation in TM4
gene 17 that results in the substitution of a glycine residue
for the highly conserved tryptophan at the centre of mt3
(amino acid residue 853 in gp17; Fig. 1). Structure of the
phAE8717W853G mutant was conﬁrmed by sequencing
and restriction analysis.
TM4 Tmp mt3 is not required for phage viability
DNA of phAE87, the phAE87D17mt3 deletion derivative,
and the phAE8717W853G point mutant were electropo-
rated into M. smegmatis and plaques recovered at 30°C
(because phAE87 and the mutants are conditionally
replicating derivatives of TM4; Bardarov et al., 1997).
Plaques were recovered from both mutants at similar
frequencies to those of their phAE87 parent and no
obvious differences in plaque morphology were observed.
Thus Tmp mt3 is not essential for growth of TM4. Never-
theless, the relationship between the length of the phage
tape measure genes and virion tail lengths is well estab-
lished, and the 342 bp deletion in TM4 gene 17 is
expected to reduce the Tmp by 114 amino acids (Fig. 4A)
with a correspondent tail length shortening of about 17 nm
Fig. 3. Construction of a hybrid protein
carrying TM4 Tmp mt3.
A. Schematic representation of TM4 gp17
Tmp and MSMEG3721 showing the position
of mt3. A hybrid protein was created by
replacing mt3 in MSMEG3721 with the motif
present in the Tmp of TM4.
B. E. coli cell extracts expressing the
indicated proteins were separated by
SDS-PAGE (left panel) or separated and
analysed in a zymogram for
peptidoglycan-hydrolysing activity (right
panel). Lanes 1 and 4, extract of E. coli cells
transformed with pET-28a (empty vector);
lanes 2 and 5, E. coli cell extracts
overexpressing MSMEG3721; lanes 3 and 6,
E. coli cell extracts overexpressing the hybrid
protein.
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phAE87D17mt3 showed that it possesses tails that are on
average approximately 20 nm shorter than those of
phAE87, in good agreement with the predicted value
(Fig. 6). This not only conﬁrms the role of gp17 in deter-
mining TM4 tail length, but also independently validates
the construction of the deletion mutant. As expected, the
tail length of the phAE8717W853G mutant is indistin-
guishable from that of the parent phage (data not shown).
TM4 Tmp mt3 is required for efficient infection of
stationary phase cells
Initial characterization of the Tmp mutants did not reveal
any obvious differences from the parent phage strain. Not
only are the plaque morphologies identical to phAE87 but
the growth patterns in liquid infections are similar and
there are no obvious effects of temperature on plating
efficiency (Figs S2 and S3). In light of the putative role of
Fig. 4. Construction of TM4 deletion mutant lacking Tmp mt3.
A. Schematic representation of TM4 gp17 Tmp showing the position of mt3 and the expected product after its deletion.
B. Schematic representation of the PCR method used to increase the length of homology in the targeting vector. A 200 bp targeting fragment
was obtained from a 100-mer oligonucleotide with 50 bases of homology to each side of the deletion and two 72-mers to generate a 342 bp
deletion in TM4 gene 17 (adapted from Swaminathan et al., 2001).
C. Identiﬁcation of mutant clones by PCR. Phasmids extracted from pools of cells recovered without selection (approximately three cells/pool)
were analysed by PCR using primers that distinguish wild-type and mutant forms of gene 17 and the products analysed by agarose gel
electrophoresis; the amplicon obtained from wt gene 17 is 939 bp and from gene D17 mt3 is 597 bp. Lanes 3–20 contain 18 representative
pools and those containing the phAE87D17mt3 mutant are marked with an arrow; lane 1 is a parental phAE87 control template and lane 2 is a
DNA size marker. Of the total 93 pools tested, 23 contained at least one deletion derivative, and we estimate that the frequency of mutants in
the recovered cells is about one recombinant per 12 electroporated cells.
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described above and peptidoglycan hydrolytic activity of
TM4 Tmp mt3 – together with previous observations
showing that the degree of peptidoglycan cross-linking is
signiﬁcantly increased in stationary phase cells of both
E. coli and Bacillus spp. (Fordham and Gilvarg, 1974;
Pisabarro et al., 1985; Atrih et al., 1999) – we examined
the ability of phAE87D17mt3 to infect M. smegmatis at
different growth stages of host cells.At all times up to 24 h
after inoculation – at which time the cells are just entering
stationary phase (Fig. 7A) – the plating efficiencies rela-
tive to exponential growing cells of phAE87D17mt3 and its
Fig. 5. Construction of a point mutant in TM4 Tmp mt3. To construct a point mutation in the shuttle phasmid phAE87, two complementary
single-strand oligonucleotides (100-mer) containing a T→G substitution that changes a TGG for a GGG codon (W853G) in gene 17 were
electroporated into an E. coli recombineering strain and pools of recovered cells screened ﬁrst by allele-speciﬁc PCR ampliﬁcation
(MAMA-PCR) (Cha et al., 1992), and then by diagnostic restriction digestion.
A. Schematic representation of MAMA-PCR. A detection primer (reverse primer) with a two-base mismatch at the 3′ does not efficiently
amplify the wild-type sequence under the PCR conditions used (see Experimental procedures), although the same primer anneals with the
mutated sequence and effectively ampliﬁes a 568 bp product.
B. PCR to identify positive clones after recombineering. Pools of recombineering products (approximately ﬁve cells/pool) were analysed by
MAMA-PCR and the products analysed by agarose gel electrophoresis. Lanes 2–19 contain representative pools, and those containing
phasmids with the desired single base substitution T→G (phAE8717W853G) are indicated with an arrow. Lane 1 contains parent control DNA
and lane 20 is a DNA marker. Of the 93 pools tested, 25 contained at least one mutant derivative, corresponding to a frequency of
approximately one recombinant per 20 electroporated cells.
C. Diagnostic restriction analysis of phAE8717W853G. Positive recombineering pools were used to transform XL-Blue cells and individual
recovered phasmids used as substrates in a second round of MAMA-PCR. Independently recovered clones were tested by ampliﬁcation of a
939 bp fragment containing the mutant region of TM4 gene 17, followed by digestion with Pvu I. The T→G substitution generates a new Pvu I
site that is absent in the original sequence so that digestion generates 409 bp and 528 bp fragments. Uncut (U) and cut (C) products of two
positive (#1 and 2) and two negative (#3 and 4) clones are shown.
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after 24 h of growth the phAE87D17mt3 mutant exhibits a
reproducible reduction in plating efficiency of about 50%
(Fig. 7B). Clearly, the mutant is defective in its ability to
infect M. smegmatis cells when they are in stationary
phase.
To determine that this phenotype results from loss of a
functional mt3 in the Tmp and not as a direct conse-
quence of tail shortening (Fig. 6), we analysed the behav-
iour of phAE8717W853G under similar conditions. The
phAE8717W853G mutant shows a similar phenotype to
the deletion mutant although the reduction in infection of
stationary cells is more modest than with the deletion
mutant (Fig. 7C). Construction of an analogous mutant
derivative of the TM4 gp17/MSMEG3721 hybrid protein
described above (Fig. 3A) does not completely eliminate
activity in a zymogram assay (data not shown), consistent
with the intermediate effect on plating efficiency. However,
the behaviour of phAE8717W853G eliminates the possi-
bility that tail shortening is responsible for the phenotype
observed with the deletion derivative.
The reduction in ability to infect stationary phase cells
could result either from a change in the ability to adsorb to
host cells, or from a defect in the process of DNAinjection;
post injection processes (such as virion assembly) seem
unlikely because the host cells are growing actively during
the formation of bacterial lawns and plaque formation, and
Fig. 6. phAE87D17mt3 is viable but has shorter tails that its parent
phage. Electron micrographs of representative particles of phAE87
(A) and phAE87D17mt3 (B). The average tail length is
200  10 nm for phAE87 and 180  6 for phAE87D17mt3. The tail
lengths of 30 individual phage particles for each phage were
measured.
Fig. 7. Plating efficiency of wt and mutant phages using cells from
different growth phases.
A. Growth curve of M. smegmatis mc
2155 at 37°C in 7H9 + ADC.
The arrows indicate the time points when cells were removed and
used in a plaque assay with phAE87 and phAE87D17mt3.
B. Light grey bars correspond to phAE87 and dark grey bars to
phAE87D17mt3. Plating efficiency was calculated relative to the
phage titer at 30°C using cells in late exponential phase of growth
(19 h).
C. Light grey bar corresponds to phAE87, dark grey bar to
phAE87D17mt3 and white bar to phAE8717W853G. Relative
plating efficiencies were calculated by comparing the phage titer at
30°C using cells in stationary phase (48 h) relative to the phage
titer at 30°C using cells in late exponential phase of growth.
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adsorption assays reveal no differences between
phAE87D17mt3 and phAE87 using either exponentially
growing or stationary phase cells (Fig. 8), and thus a loss
of adsorption does not account for the defect in infection
of stationary phase cells.
To determine whether DNA injection was altered in
the phAE87D17mt3 mutant we constructed luciferase
reporter phage derivatives of phAE87D17mt3 and
phAE87. Upon infection of exponentially growing
M. smegmatis cells both phages gave similar patterns of
light emission related to those reported previously for TM4
reporter phages (Fig. 9A) (Jacobs et al., 1993). However,
we observed a signiﬁcant reduction in light output from the
phAE87D17mt3 mutant phage relative to its parent when
the host cells were grown to stationary phase and resus-
Fig. 8. Adsorption assay. Adsorption of phAE87 () and
phAE87D17mt3 ().
A. Adsorption to M. smegmatis mc
2155 cells from exponential
phase.
B. Adsorption to cells from stationary phase resuspended in spent
medium.
Fig. 9. Kinetics of luciferase activity. Kinetics of luciferase activity
(relative luciferase units, RLU) after infection with phAE87::FFlux
() and phAE87D17mt3::FFlux ().
A. Exponential phase cells.
B. Stationary phase cells resuspended in spent medium.
C. Stationary phase cells resuspended in fresh medium.
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constant cell density. While the overall level of light pro-
duction from both phages is reduced relative to exponen-
tially growing cells, we observed a reproducible reduction
in light output from phAE87D17mt3 relative to the parent
phage (Fig. 9B). For time points up to about 100 min post
infection, the phAE87D17mt3 activities were approxi-
mately 50% those of the parent, consistent with the reduc-
tion in plating efficiencies shown in Fig. 7. When
stationary phase cells were resuspended in fresh media
such that they were competent to begin growth – as
described previously (Smeulders et al., 1999) – we
observed a signiﬁcant amelioration of the mutant defect
(Fig. 9C). We note that luciferase reporter phages derived
from mycobacteriophage L5 (Sarkis et al., 1995) also
show a reduction in light output following infection of cells
with cell wall alterations (Barsom and Hatfull, 1996).
Discussion
We have described here a role for the peptidoglycan-
degrading activity within the tape measure protein of
mycobacteriophage TM4 that facilitates the efficient infec-
tion of stationary phase bacterial cells. While we have
only demonstrated this activity for the phage TM4, it is
plausible that other mycobacteriophages with Tmp’s
containing mt3 (i.e. Che8 and Omega) may act similarly,
in spite of sequence variations within the motif itself
(see Fig. 1). As Micrococcus luteus Rpf also has
peptidoglycan-degrading activity (Telkov et al., 2006), it
seems plausible that peptidoglycan degradation may be a
common activity of all three of the sequence motifs that
are located within mycobacteriophage Tmp’s.
The presence of mt3 in the TM4 Tmp clearly facilitates
infection of cells in stationary phase, and it would not be
surprising if this provides a selective advantage to phage
propagation in natural environments. However, little is
known about the speciﬁc growth states of host cells that
mycobacteriophages encounter in such environments,
although it seems probable that they are more likely to be
growing in bioﬁlm communities rather than as exponen-
tially growing cells in a nutritionally rich medium. While the
fate of attempts by phage particles to infect non-growing
cells is not clear, the data presented here suggest that the
peptidoglycan-degrading motif facilitates this process.
However, the peptidoglycan-degrading activities of the
Rpf-related proteins are also required for stimulating the
growth of dormant bacteria, and it is thus plausible that
mt3 performs a similar function, in addition to enabling the
injection of phage DNA into non-growing cells.
There are many possible reasons to account for the
inability of seeing peptidoglycan modifying activity directly
from the phage including the amount and renaturation
properties of this large protein. However, it is also plau-
sible that proteolytic processing is required to activate the
enzymatic activity of this motif, and we note that pro-
teolytic maturation of T4 gp5 is required for full activation
of its enzymatic potential (Kanamaru et al., 2005). Pro-
teolytic processing is also common among phage Tmp’s
and may occur at the C-or N-termini, or even lead to loss
of an internal segment (Tsui and Hendrix, 1983; Pedersen
et al., 2000). Processing of TM4 gp17 has not been
described in detail although the fate of labelled proteins
during phage infection suggests that it is proteolytically
processed (Ford et al., 1998). Nevertheless, the motif
itself does appear to contain peptidoglycan-hydrolysing
potential, because it exhibits this activity when incorpo-
rated as part of a hybrid protein with MSMEG3721.
The fate of tape measure proteins during an infectious
cycle is unclear although they presumably must exit the
lumen of the tail in order to provide passage for the DNA
into the cell. There are few studies exploring this question,
although Roessner and Ihler proposed that the tape
measure protein of phage lambda is associated with the
membrane and may play a role in forming a transmem-
brane hole through which the DNA traverses (Roessner
and Ihler, 1984). This is an attractive explanation for the
role of all tape measure proteins and is consistent with the
requirement for peptidoglycan degradation in order to
reach the cellular membrane. It has also been proposed
(Molineux, 2006) that ejection of the Tmp from the tail
lumen could be responsible for transducing a signal from
the tail component in contact with the cell surface to the
head to initiate DNA ejection. Peptidoglycan hydrolytic
activity of mt3 could thus facilitate DNA injection into the
host cell.
The observation that TM4 Tmp mt3 is not essential for
phage infection is consistent with the ﬁnding that the
murein hydrolase activities of T4, T7, PRD1 and f6 (Naka-
gawa et al., 1985; Moak and Molineux, 2000; Rydman
and Bamford, 2000; Kanamaru et al., 2002) are also not
required for infection. Interestingly, mutants defective in
T7 gp16 exhibit modest defects in either the latent period,
lysis time, or the efficiency of plating (Moak and Molineux,
2000), with the greatest effects when cells are entering
stationary phase when the peptidoglycan is more highly
cross-linked (Pisabarro et al., 1985). As phAE87D17mt3
also shows a defect in the infection of stationary phase
cells, this raises the intriguing possibility that the TM4 Tmp
is performing a similar role in infection to that of T7 gp16.
Remarkably, a substitution of one of the conserved resi-
dues in mt3 led to a similar phenotype, corroborating that
the phenotype observed was consequence of the lack of
the motif in the Tmp and not just a result of a short tail in
phAE87D17mt3. However, construction of the analogous
TM4gp17W853G amino acid substitution in the
MSMEG3721 hybrid protein did not completely obliterate
peptidoglycan hydrolysis in a zymogram (data not shown)
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more modest reduction in plating efficiency (to only
60% in phAE8717W853G compared with 50% in
phAE87D17mt3). We note that a different substitution (in
the putative catalytic glutamate residue) in the Micrococ-
cus luteus Rpf also exhibits activity in a zymogram but is
attenuated using other assays (Mukamolova et al., 2006).
As the zymogram provides only a qualitative measure of
muralytic activity, an in vitro assay to quantify the exact
activity reduction in the mutant proteins and to further
characterize the type of activity of mt3 would be helpful.
It remains unclear, however, why the defects in
phAE87D17mt3 and phAE8717W853G lead to a ~50%
reduction in infection, although it could be due to either a
uniform loss in infectivity, or possibly reﬂect a proposed
physiological heterogeneity of stationary phase cells
(Blokpoel et al., 2005).
While mycobacterial growth state-dependent changes
in peptidoglycan cross-linking have yet to be described,
we note that this not only occurs in E. coli – where murein
cross-linking increases at the transition from exponential
growth to stationary phase and continues for the next 12 h
(Pisabarro et al., 1985) and L,D-cross-links are found in
the peptidoglycan of stationary phase cells (Templin et al.,
1999) – but similarly in Gram-positive bacteria such as
B. subtilis and Bacillus megaterium (Fordham and
Gilvarg, 1974; Atrih and Foster, 1999). We also note that
dilution of stationary phase mycobacterial cells into fresh
medium ameliorates the difference exhibited by the
phAE87D17mt3 mutant consistent with the idea that the
peptidoglycan is rapidly remodelled in growing cells as
shown in E. coli (Pisabarro et al., 1985). We therefore
predict that there are signiﬁcant changes – either qualita-
tively and/or quantitatively – in the peptidoglycan of myco-
bacteria depending on the growth phase of the cells.
The studies reported here provide strong support for
the role of a peptidoglycan hydrolase activity of the TM4
Tmp, and we predict that all three of the previously
described motifs will play similar roles. However, it is
unclear whether those mycobacteriophages that do not
appear to harbour one of three motifs are simply at a
selective disadvantage to those that do, whether they also
have peptidoglycan-hydrolysing activities that have yet to
be identiﬁed bioinformatically, or whether they possibly
naturally infect hosts whose peptidoglycan structures do
not prevent barriers to infection, even in stationary phase
cells. Peptidoglycan-hydrolysing motifs corresponding to
peptidase and transglycosylase activities are located
within tape measure proteins of phages that infect other
Gram-positive bacteria – including Gordonia terrae, Sta-
phylococcus aureus, Lactobacillus spp., B. megaterium
and Mycobacterium vanbaalenii – suggesting that this is a
common strategy employed by phages of Gram-positive
bacterial hosts.
Experimental procedures
Bacterial strains and growth
Mycobacterium smegmatis mc
2155 was grown at 37°C in
Middlebrock 7H9 broth (Difco), containing ADC (2 g l
-1 Dex-
trose, 5 g l
-1 Albumine, 0.85 g l
-1 NaCl) or 2 g l
-1 of succinate
or acetamide and 0.05% Tween 80. Tween was omitted when
cultures were used for phage infection. When appropriate,
antibiotics were added at the following concentrations: kana-
mycin 25 mgm l
-1, hygromycin 150 mgm l
-1. E. coli strains
were grown in L-Broth.
Plasmids used in this study are described in Table 2.
Cell localization experiments
Plasmids pMP1 and pMP2 were used to transform
M. smegmatis mc
2155 electrocompetent cells. Cells were
grown in regular media to exponential phase and subjected to
differential cell fractioning as described below. M. smegmatis
mc
2155 was also transformed with plasmid pMP4 (Table 2)
and cells were grown in TH9 media containing succinate
(uninduced) or succinate plus acetamide (induced). Cells
were grown in 30 ml medium to exponential phase, har-
vested, and the supernatant recovered. After ﬁltration,
0.015% sodium deoxycholate was added to the supernatant
with shaking for 10 min at room temperature; trichloroacetic
acid (ﬁnal concentration 10%) was added and tubes kept for
1 h at 4°C. The pellet was recovered after centrifugation at
4000 g for 15 min at 4°C, washed twice with cold acetone and
resuspended in phosphate-buffered saline (PBS) (superna-
tant fraction). The cell pellets were resuspended in 3 ml of
PBS containing 1 mM PMSF and sonicated 10 times with
20 s pulses. After centrifugation at 11 000 g for 15 min to
remove entire cells and insoluble material, the supernatant
was centrifuged at 27 000 g for 1 h at 4°C. The pellet was
resuspended in 300 ml of PBS (cell wall fraction) and the
supernatant centrifuged at 100 000 g for 1 h at 4°C. The
pellet was resuspended in 300 ml of PBS corresponded to the
cell membrane fraction and the supernatant was the cyto-
plasm fraction. Protein concentrations of all fractions were
determined using the BIORAD protein estimation kit (cat#
500-0006). Ten micrograms of total protein per sample was
loaded on 12% PAGE, blotted onto PVDF membrane and
probed with a rabbit anti-MSMEG3721 polyclonal antiserum
raised against recombinant MSMEG3721 (1:1000 dilution).
Peroxidase-conjugated anti-rabbit IgG (Sigma, A-0545) was
used as a secondary antibody (1:10 000 dilution) and detec-
tion was carried out using the Western Lightening Reagent
(Perkin Elmer) according to the manufacturer’s instructions.
Construction of mutants
The chromosomal copy of MSMEG0642 was interrupted
using a specialized transducing phage as described previ-
ously, using plasmid pMP6 as the source for allelic exchange
(Bardarov et al., 2002). To generate MSMEG3721 and
MSMEG6076 mutants (MSMEG3721::res-hyg-res and
MSMEG6076::res-hyg-res), we used a recombineering-
based system in M. smegmatis (J.C. van Kessel and G.F.
Hatfull, submitted). Brieﬂy, M. smegmatis mc
2155 was trans-
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succinate and recombineering functions were induced for 3 h
with acetamide. After that time electrocompetent cells were
made and transformed with 100 ng of linearized plasmid
pMP5 or pMP7 DNA. After recovery, cells were plated in the
presence of kanamycin and hygromycin and incubated for
4 days at 37°C. Ten colonies were checked for gene replace-
ment by colony PCR and one positive clone for each mutant
was cured from plasmid pJV24, checked by Southern Blot
and used for further studies. To generate the MSMEG3721/
MSMEG0642 double mutant (MSMEG0642D/3721::res-hyg-
res), we transformed MSMEG0642::res-hyg-res with
pGH542 that express the gd resolvase. After recombination
between the res sites, the Hyg
R cassette is removed and lost
in subsequent cell divisions, rendering strain MSMEG0642D,
Hyg
S. This resultant strain was transformed with pJV24 and
after induction of recombineering functions as described
above, was transformed with linearized pMP5 to interrupt
the chromosomal copy of MSMEG3721. The double mutant
strain was cured from plasmid pJV24 checked by Southern
Blot and used for further studies. For complementation
assays MSMEG0642D/3721::res-hyg-res was transformed
with plasmids pPG1 (empty vector control), pMP8 or
pMP9.
Minimal inhibitory concentration (MIC) calculations
Wild-type and mutant strains were grown to exponential
phase and diluted to an initial OD600 of 0.005 in Middlebrock
7H9 broth containing ADC and 0.05% Tween 80 in the pres-
ence of different concentrations of vancomycin (0–0.3–0.6–
1.25–2.5–5-10 mgm l
-1). For the plasmid containing strains,
kanamycin (25 mgm l
-1) was also included. Cultures were
incubated at 37°C for 48 h; the OD600 reached was measured
and the percentage of growth for each vancomycin concen-
tration was plotted. The minimal concentration of vancomycin
that inhibited growth (MIC) was calculated from the graph
(Fig. S1). Experiments were done in triplicate and the stan-
dard deviation (SD) was calculated.
Puriﬁcation of MSMEG3721 and MSMEG0642
recombinant proteins
N-terminal his-tagged MSMEG3721 and MSMEG0642
Table 2. Plasmids used in this study.
Plasmid Characteristics Source or reference
pJL37 Shuttle plasmid, Kan
R, oriM, oriE, M. bovis BCG hsp60 promoter Lewis and Hatfull (2000)
pMP1 pJL37 containing MSMEG3721 CDS with the putative SP (NdeI-HindIII) This work
pMP2 pJL37 containing MSMEG3721 CDS without the putative SP
(NdeI-HindIII)
This work
pLAM12 Derivative of pJL37, BCG hsp60 promoter was replaced with an
acetamidase promoter from pSD26
Lab collection
pMP3 pLAM12 containing MSMEG3721 CDS with the putative SP
(NdeI-HindIII)
This work
pMH94 Mycobacteria integrative vector, Kan
R, L5 attP and integrase Lee et al. (1991)
pMP4 pMH94 containing MSMEG3721 CDS with the putative SP under control
of acetamidase promoter from pMP3 (XbaI-NheI)
This work
pYUB854 Cosmid, oriE, Hyg
R, res-hyg-res Bardarov et al. (2002)
pMP5 pYUB854 containing 5′ and 3′ region of MSMEG3721 and 600 bp of
upstream and downstream DNA (XbaI-XmaI and XhoI-BstBI)
This work
pMP6 pYUB854 containing 5′ and 3′ region of MSMEG0642 and 600 bp of
upstream and downstream DNA (KpnI-XbaI and XhoI-BglII)
This work
pMP7 pYUB854 containing 5′ and 3′ region of MSMEG6076 and 600 bp of
upstream and downstream DNA (AﬂII-XbaI and HindIII-XhoI)
This work
pPG1 Derivative of pJL37 lacking the BCG hsp60 promoter Ghosh et al. (2006)
pMP8 pPG1 containing MSMEG3721 gene with the putative promoter and
transcription terminator sequences (PCR fragment cloned in BsaAI)
This work
pMP9 pPG1 containing MSMEG0642 gene with the putative promoter and
transcription terminator sequences (PCR fragment cloned in BsaAI)
This work
pET-28a Cloning/inducible expression vector, Kan
R, N-terminal His Tag Novagen
pMP10 pET-28a containing MSMEG3721 CDS without the putative SP
(NdeI-HindIII)
This work
pMP11 pET-28a containing MSMEG0642 CDS without the putative SP
(NdeI-HindIII)
This work
pMP12 pET-28a containing MSMEG3721 TM4 Tmp mt3 (hybrid protein)
(NdeI-HindIII)
This work
phAE87 pH101::pYUB328 that fails to replicate at 37°C. PH101 is a ts mutant of
TM4, Amp
R
Bardarov et al. (1997)
phAE87D17mt3 pHAE87D mt3 in gene 17 This work
phAE8717mt3W4G phAE87 with a single base change T-G in gene 17 that generates a W4G
substitution in Tmp mt3
This work
pYUB556 Cosmid, Kan
R, oriE and FFlux under control of BCG hsp60 promoter Carriere et al. (1997)
pJV24 Kan
R, oriM, Che9c gp59–62 under control of acetamidase promoter J.C. van Kessel and G.F. Hatfull
(submitted)
pGH542 Tet
R, oriM, gd resolvase under control of BCG hsp60 promoter Lab collection
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(DE3) (Invitrogen) transformed with plasmids pMP10 and
pMP11 respectively. In addition, empty vector pET-28a was
also transformed into E. coli BL21 (DE3) and prepared in
parallel as a negative control. Transformed cells were grown
at 37°C to an OD600 of 0.6 and protein expression was
induced by addition of 0.5 mM IPTG, cells were left overnight
at room temperature before harvesting. Cells pellets were
resuspended in binding buffer (50 mM Tris-HCl pH 8,
300 mM NaCl, 5% glycerol and 1 mM PMSF) and disrupted
by sonication (4 ¥ 15 s). The lysate was centrifuged at
20 000 g for 20 min, and the supernatants incubated with
2 ml pre-equilibrated Ni-Agarose for 2 h at 4°C. The matrix
was washed with 20 vols of binding buffer, 10 vols of the
same buffer containing 10 mM imidazole and 5 vols contain-
ing 20 mM imidazole. Elution was done with 4 vols of buffer
with 60 mM imidazole. Eluted samples were dialysed twice
against binding buffer and a last time in the same buffer but
containing 50% glycerol and stored at -20°C.
Construction of a hybrid protein carrying TM4 Tmp mt3
To construct a MSMEG3721 hybrid protein where the con-
served motif was replaced with the Tmp mt3 of TM4, a PCR
cloning strategy was used. A PCR product containing gene
17 mt3 and 25 bp of homology to the 5′ and 3′ regions of
MSMEG3721 ﬂanking mt3 was generated. Two more indi-
vidual PCR products were generated corresponding to the
5′ and 3′ region of MSMEG3721 excluding the sequence
coding for the conserved motif and the putative SP. The
three generated products were used as substrates in a PCR
reaction to obtain a full-length amplicon that corresponds to
the DNA sequence coding for the hybrid protein. Outside
primers (MSMEG3721 Wout/SP F and R, Table S2) that
amplify the whole product and contained restriction sites to
clone in pET28 were included in this reaction. After cloning
in pET28, pMP12 was generated. Plasmid pMP12 was
used to transform E. coli BL21 (DE3) (Invitrogen) as
described above and a cell extract expressing the hybrid
protein was tested for activity in zymogram assay. After
expression in pET28 the composition of the hybrid protein
will be: 21 amino acids in the N-terminal region (containing
the His-tag) (replacing the putative SP – 25 amino acids),
62 amino acids of MSMEG3721, 114 amino acids corre-
sponding to TM4 Tmp mt3 and 22 ﬁnal amino acids of
MSMEG3721.
Zymogram analysis
Protein samples (5–10 mg) were boiled for 3 min in sample
buffer (62.5 mM Tris-HCl pH 6.8, 2% SDS, 20% Glycerol, 5%
b-mercaptoethanol, 0.1% Bromophenol Blue) and loaded
onto 12% polyacrylamide gels containing 0.1% Micrococcus
luteus peptidoglycan (Sigma 53243). Gels were cast accord-
ing to Laemmli (1970) but with only 0.01% SDS. After
running, the gel was incubated at 37°C for 16 h in 1% Triton
X-100, 25 mM Tris-HCl pH 8.5; washed once in water,
stained for 3 h with 0.5% Methylene Blue in 0.01% KOH and
destained with water. Peptidoglycan hydrolase activity is
detected as a clear zone in a blue background of stained
peptidoglycan. Gels not containing peptidoglycan were
stained with Coomassie Brilliant Blue. Lysozyme and
b-casein used as controls were purchased from Sigma.
Construction of mutant TM4 phages using
recombineering in E. coli
Escherichia coli strain DY331 carrying a defective l proph-
age harbouring the recombination genes exo, bet and gam
under the control of temperature-sensitive cI repressor, was
used for phAE87 modiﬁcation. Phasmid phAE87 is a condi-
tional shuttle phasmid vector that contains the TM4 genome
and can replicate as a plasmid in E. coli and as a phage in
mycobacteria at 30°C but not at 37°C. DY331 cells were
induced and made electrocompetent as described (Thoma-
son and Oppenheim, 2005). Brieﬂy, 25 ml of cells grown at
30°C to an OD600 of 0.6 was induced at 42°C for 15 min. After
being chilled on ice for 15 min, cells were washed with ice-
cold water three times and resuspended in 500 ml of ice-cold
water and used immediately for electroporation. To generate
the deletion of mt3 in gene 17 of TM4 genome a 200 bp PCR
targeting vector was constructed using a method described
previously (Swaminathan et al., 2001). Brieﬂy, three primers
were designed: a 100-mer oligonucleotide with 50-base
homology from either side of the region to be deleted
(Recombineering Oligo), and two 72-mer external primers,
one forward and one reverse, with 22-base overlaps on either
side of the 100-mer (recombineering 50 bp more F and R)
(Table S2). Combination-PCR was carried out by mixing
10 ng of the 100-mer and 300 ng of the 72-mers in a 100 ml
PCR reaction using the Cloned Pfu DNA polymerase
(Stratagene). The resultant PCR product, a 200-mer targeting
cassette, was extracted from the gel using the QIAquick Gel
Extraction Kit (Qiagen) and reconstituted in sterile water. The
PCR product was denaturated at 95°C for 10 min and quick
chilled on ice prior to use for electroporation.
Approximately 100 ml of freshly prepared electrocompetent
DY331 cells were co-transformed with 500 ng of phAE87 and
200 ng of the 200-mer targeting cassette. Phasmid phAE87
contains a ColE1 origin of replication, and induction of Gam
expression in DY331 inactivates RecBCD nuclease. In the
absence of RecBCD, ColE1 containing plasmids replicate by
a rolling circle mode, and the plasmid converts from mono-
mers to multimers. By co-electroporating the recA
– strain
DY331 with phAE87 and the linear targeting cassette recom-
binant plasmid monomers can be readily selected and iso-
lated (Yu et al., 2000). After electroporation cells were
resuspended in 1 ml of Luria–Bertani medium and recovered
at 30°C for 2 h. Cells were diluted and plated in 1-ml-deep
96 well plates at about 5–10 cells per well. The cells were
grown at 30°C for about 24 h in the presence of carbenicillin
50 mgm l
-1 and tetracycline 12.5 mgm l
-1. The number of cells
per well was determined by plating serial dilutions of elec-
troporated cells on agar plates. After 24 h, phasmids from
each pool of cells were isolated using a Qiagen BioRobot™
9600 nucleic acid puriﬁcation system and analysed by PCR.
One of the samples containing phAE87D17mt3 was used to
transform XL-Blue competent cells. Twenty-ﬁve colonies
were analysed to ﬁnd a clone containing only the modiﬁed
phasmid. Phasmid mutant phAE87D17mt3 was checked by
restriction analysis and sequencing. In all the analysed phas-
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precisely the region corresponding to mt3.
A similar strategy was used to generate a single base
change in phAE87, T12741G that changes a TGG for a
GGG codon (W853G) in gene 17. In this case, two comple-
mentary single-strand 100-mer oligonucleotides (Recom-
bineering Oligo T→G + and –) in which a T in the original
sequence was replaced by a G were used as substrates.
Recombination was also performed in E. coli without selec-
tion and phasmids isolated from pools of recovered cells
screened by an allele-speciﬁc PCR ampliﬁcation called the
mismatch ampliﬁcation mutation assay (MAMA-PCR) (Cha
et al., 1992). A detection primer containing a two-base mis-
match to the wild-type sequence but only a penultimate
base mismatch to the point mutation at its 3′ end (MAMA-
PCR R) was used along with a forward primer (MAMA-PCR
F). The PCR condition included denaturation for 4 min at
94°C followed by 40 cycles of 94°C for 15 s and 77°C for
1 min (a common annealing and extension temperature)
and a ﬁnal extension at 72°C for 7 min. These primers
amplify a 568 bp product. Two positive clones were used to
transform XL-Blue cells and in 20 clones of each the pres-
ence of a single phasmid containing the desired mutation
was checked by a second round of MAMA-PCR and cor-
roborated by restriction analysis of a 939 bp PCR product
ampliﬁed from the mutated region. The base change
created a new Pvu I site absent in the original sequence, so
after restriction digestion the mutated PCR product gener-
ates two fragments of 528 and 409 bp. Phasmid mutant
phAE8717W853G was checked by restriction analysis and
sequencing. Three clones, one of phAE87, one of
phAE87D17mt3 and other of phAE8717W853G, were used
to transform M. smegmatis in order to recover plaques and
generate phage stocks for use in further experiments.
Construction of phAE87::FFlux phages
To construct phAE87 and phAE87D17mt3 carrying a
luciferase gene, plasmid pYUB328 was replaced for
pYUB556 containing the luciferase cassette. Plasmid
pYUB556 is a derivative of pUB216, where Amp
R was
replaced for a Kan
R cassette (Jacobs et al., 1993). Brieﬂy,
phAE87 and phAE87D17mt3 were digested with NotI and
ligated to pYUB556 cut with the same enzyme. About 100 ng
of the ligation mix was packaged using an in vitro
l-packaging reaction (Gigapack III XL-7, Stratagene). After
transducing E. coli HB101 and plating the transductants on
selective media containing kanamycin, phasmid DNA was
prepared from 10 colonies of each transduction and checked
by restriction analysis. Two clones, one of phAE87 and other
of phAE87D17mt3, were used to transform M. smegmatis in
order to recover plaques and generate a phage stock of
phAE87::FFlux and phAE87D17mt3::FFlux to use in further
experiments.
Luciferase assays
Luciferase assays were performed as already described
(Sarkis et al., 1995). Cells were grown to exponential phase
or stationary phase and diluted to an initial OD600 of 0.1. When
stationary phase cells were used, 5 ml of culture was centri-
fuged and resuspended in the same volume of either fresh
medium (7H9 broth containing ADC, without Tween) or ﬁl-
tered spent medium and subsequently diluted to an initial
OD600 of 0.1 in fresh or spent medium respectively. Assays
were initiated by addition of 0.1 ml of phages (10
10 pfu ml
-1)t o
0.9 ml of cells (10
7 cfu ml
-1, moi: 100). Cultures were incu-
bated standing at 37°C for 15 min and then with agitation. At
various time points, a 50 ml aliquot was removed after vortex-
ing the sample for about 10 s. The aliquot was placed in a
polystyrene cuvette (Monolight 2050–10) and light output
was measured for 20 s after the injection of the substrate
[100 ml of 1 mM D-luciferin (BD Biosciences, 556876) in
0.1 M sodium citrate, pH 5] in an Analytical Luminescence
Laboratory Monolight 2010 single injector luminometer.
Adsorption assays
About 1.5 ¥ 10
8 cells from exponential and stationary phase
were incubated with 7 ¥ 10
3 phages (moi: 0.00005) at 30°C
either in fresh or spent media in 3 ml ﬁnal volume. At the
indicated time points, 120 ml of aliquots was removed, after
vortexing for 5 s, and centrifuged for 1 min at 13 000 rpm to
remove cells. One hundred microlitres of the supernatant was
mixed with a 100 ml of exponential cells, incubated at 30°C for
30 min and mixed with 3 ml of TH10 Top Agar that was
quickly poured onto a pre-warmed TH10 plate. Plaques were
visible after incubation at 30°C for 48 h.
Bioinformatic analyses
Identiﬁcation and comparison of conserved sequence motifs
were performed using ProDom (http://prodom.prabi.fr/
prodom/current/html/home.php), and signal sequences were
identiﬁed using Signal P 3.0 (http://www.cbs.dtu.dk/services/
SignalP) (Nielsen and Krogh, 1998; Bendtsen et al., 2004).
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